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Abstract
Background: Bacterial infection of the urinary tract is a common clinical problem with E. coli being
the most common urinary pathogen. Bacterial uptake into epithelial cells is increasingly recognised
as an important feature of infection. Bacterial virulence factors, especially fimbrial adhesins, have
been conclusively shown to promote host cell invasion. Our recent study reported that C3
opsonisation markedly increases the ability of E. coli strain J96 to internalise into human proximal
tubular epithelial cells via CD46, a complement regulatory protein expressed on host cell
membrane. In this study, we further assessed whether C3-dependent internalisation by human
tubular epithelial cells is a general feature of uropathogenic E. coli and investigated features of the
bacterial phenotype that may account for any heterogeneity.
Results: In 31 clinical isolates of E. coli tested, C3-dependent internalisation was evident in 10
isolates. Type 1 fimbriae mediated-binding is essential for C3-dependent internalisation as shown
by phenotypic association, type 1 fimbrial blockade with soluble ligand (mannose) and by
assessment of a type 1 fimbrial mutant.
Conclusion: we propose that efficient internalisation of uropathogenic E. coli by the human urinary
tract depends on co-operation between type 1 fimbriae-mediated adhesion and C3 receptor -ligand
interaction.
Background
Urinary tract infection (UTI) due to uropathogenic E. coli
is a common clinical problem, estimated to affect 40–
50% of women at least once in their lifetime [1]. Frequent
recurrence is an important characteristic of UTI especially
among young women. Up to 25% of women who experi-
ence a first UTI will develop recurrent infections within 6
months despite appropriate treatment of the initial infec-
tion [2].
Recent research has demonstrated that uro-epithelial cells
from the kidney and the bladder have the capacity to
internalise E. coli into membrane-bound vacuoles [3,4].
Inside cells E. coli can establish long-lived intracellular res-
ervoirs within the bladder mucosa that serve as a source
for recurrent acute infections [5,6]. E. coli encode a variety
of virulence factors that facilitate colonisation of the uri-
nary tract, such as fimbrial adhesins (type 1, P, S, and Dr
fimbriae) and toxins (α-hemolysin and cytotoxic necrotis-
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strains are usually resistant to serum bactericidal activity
[8]. Of the known virulence factors associated with E. coli,
the type 1 fimbriae associated adhesin FimH, Dr family
adhesins and bacterial toxin CNF1 have been shown to
directly trigger and/or modulate bacterial entry into host
epithelial cells [9-11].
In addition to pathogen virulence factors, complement C3
secreted by host cells also influences the ability of E. coli
to invade cells and tissues within the urinary tract. Studies
from our group have shown that mice deficient in C3 are
resistant to ascending infection and complement can alter
bacterial uptake by mouse proximal tubular epithelial
cells (PTECs), a primary target of E. coli during the acute
phase of pyelonephritis [12]. Recently we reported that C3
concentration in the urine rises sufficiently during renal
tract infection and E. coli are readily opsonised by urinary
C3 [13,14]. Moreover, C3 opsonisation promotes E. coli
invasion of human uro-epithelial cells via CD46, a com-
plement regulatory protein expressed on host cell mem-
branes [13]. CD46 was not involved in the binding of E.
coli to epithelial cells. Therefore, we hypothesised that
other bacterial factors may be involved in C3-dependent
E. coli internalisation.
In the present study, we examined whether C3-dependent
internalisation by host uro-epithelial cells is a general fea-
ture of E. coli and studied features of the bacterial pheno-
type that may account for any heterogeneity.
Internalisation of PTECs by E. coli isolatesFigure 1
Internalisation of PTECs by E. coli isolates. 16 isolates of E. coli from the urine of patients with clinical UTI (A and C) and 
15 isolated from blood cultures when the source was the urinary tract (B and D) were assessed to determine whether they 
demonstrated C3-dependent internalisation. (A) and (B) shown the number of bacteria internalised by PTECs in the presences 
of 5% NHS or HIS (mean of 4 separate wells per isolate). C3-dependent internalisation was arbitrarily defined as a 5-fold 
increase in the number of bacteria internalised in the presence of NHS compared with HIS. 7 urine isolates (43.75%) (C) and 3 
(20%) blood isolates (D) demonstrated C3-dependent internalisation. The results were reproducible in two independent 
experiments.
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Bacterial strains and culture
Bacteria were grown in 5 ml of static Luria-Bertani (LB)
broth at 37°C for 16 hours to induce fimbrial expression
prior to use in experiments. For each experiment bacterial
concentration was standardised by photospectrometry at
600 nm, and colony number confirmed using serial dilu-
tions and plating to agar plates. E. coli strain J96 (serotype
O4: K6) was provided by Dr. R. Welch, (University of Wis-
consin, Madison, USA). It is a serum resistant, haemolysin
secreting E. coli strain that expresses both Type 1 and P
fimbriae [15]. Cystitis isolate NU14 and the isogenic
FimH- mutant NU14-1 were provided by Dr. S. Hultgren
(Washington University school of Medicine, Missouri,
USA) [9]. 31 E. coli isolates were obtained from the
Department of Microbiology, Guy's and St. Thomas'
National Health Service Foundation Trust, of which, six-
teen strains were isolated from urine samples of patients
suffering from acute uncomplicated cystitis and fifteen
isolated from blood cultures with simultaneous UTI
symptoms. The urine and blood samples were spread
onto blood agar and bromothymol blue agar for the iso-
lation and identification of E. coli. Diagnosis of UTI was
made based on clinical symptoms and more than 105 col-
ony-forming units (c.f.u) of E. coli per ml of urine. Sam-
ples associated with more than one bacterial species were
excluded from the study.
Cell line and culture
The human PTEC line was a gift from Professor. L.C.
Racusen (The Johns Hopkins University School of Medi-
cine, Baltimore, USA) [16]. The cells were grown in
DMEM-F12 supplemented with 5% FCS, 5 μg/ml insulin,
5 μg/ml transferin, 5 ng/ml sodium selenium, 100 U/ml
penicillin and 100 μg/ml streptomycin.
Sera and complement inactivation
Normal human serum (NHS) was obtained from 5
healthy volunteers. After collection, serum was pooled
and stored at -70°C for up to 3 months. Complement
activity in serum was inactivated by incubation at 56°C
for 30 minutes (Heat inactivated serum, HIS). Comple-
ment inactivation was confirmed by loss of haemolytic
activity using standard methodology (data not shown).
Table 1: Phenotyping of E. coli urine isolates.
Strains Internalisation rate (NHS/HIS) Type1- fimbriae P-fimbriae CNF1 Serum resistance α-Haemolysin
J96 25 P P P P P
Internalised
U1 9.2 P P P P P
U2 6.5 P N P P P
U3 14.3 P N P P N
U4 5.5 P N N P N
U5 5.1 P N N P N
U6 15.1 P N N P N
U7 23.5 P N N P N
Non-internalised
U8 2.1 P N P P P
U9 0.55 P N P P P
U10 0.83 N P P P P
U11 1.5 N N N P N
U12 1.2 N N N P N
U13 1.9 N N N P N
U14 3.25 N N N P N
U15 1.375 N N N N N
U16 0.47 N N N N N
In 16 urine E. coli isolates, bacterial virulence factors (including type-1, P fimbriae, CNF1, serum resistance, and α-Haemolysin) were examined to 
determine their correlation to C3-dependent internalisation (P positive, N negative). All experiments were repeated at least three times.
C3 deposition on E. coli isolatesFigure 2
C3 deposition on E. coli isolates. 6 E. coli isolates (lane 3–
8) were incubated with 5% NHS in culture medium for 30 
minutes. C3 deposition was detected by Western blot analy-
sis. Lane1, Purified C3b (0.1 μg); lane 2 J96 were incubated 
with 5% NHS; lanes 3–5 isolates showing positive for C3-
dependent internalisation (U1, U5, B2); lanes 6–8, isolates 
not showing C3-dependent internalisation (U9, U13, B7). 
The presence of C3b is indicated by 105 kDa (α' chain) and 
75 kDa (β chain) bands, iC3b by 75 kDa (β chain), 67 kDa 
(α1 chain), and 40 kDa (α2 chain) bands.
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Bacteria were opsonised as described previously [14].
Briefly, 2 × 108c.f.u E. coli were washed and incubated in
DMEM-F12 containing 5% NHS at 37°C for 30 minutes.
Bacteria were washed in 10 mM EDTA to stop further
complement activation. Bacterial-bound complement
proteins were eluted with 4 mM sodium carbonate, 46
mM sodium bicarbonate (pH 9.2) for 2 hours at 37°C.
Bacteria were removed by centrifugation. Eluted proteins
were separated by 10% SDS-PAGE under reducing condi-
tions and transferred to a Hybond-c Extera membrane
(GE Healthcare UK Limited, Bucks, UK). The membrane
was sequentially incubated with blocking buffer (PBS-5%
milk powder) at 4°C overnight, rabbit anti-human C3c
(1/1000; Dako UK Ltd, Cambridgeshire, UK), and perox-
idase-conjugated goat anti-rabbit IgG (1/5000; Dako).
The membrane was then developed using the ECL system
(GE Healthcare UK Limited).
Assessment of bacterial binding and internalisation
PTECs were seeded into 24 well plates and grown to con-
fluence. Overnight cultures of E. coli were adjusted to an
OD of 0.01 at 600 nm (1 × 107 c.f.u/ml). Culture medium
was replaced with 900 μl of pre-warmed DMEM-F12 in
presence of 50 μl NHS or HIS (5%) and PTECs were
infected with 100 μl of the bacterial suspension. Bacterial
contact with host cells was increased by centrifugation of
plates at 600 g for 5 minutes. After 3 hours of incubation
at 37°C, bacteria bound to PTECs were measured by lys-
ing cells with 1% Triton X-100 after vigorous washing to
remove unattached bacteria. This would include internal-
ised bacteria, but since binding exceeded internalisation
by approximately 50 fold no correction was made. To
assess the number of internalised bacteria, after 3 hours
incubation PTECs were washed 3 times and then incu-
bated for 1 hour in medium containing 100 μg/ml
gentamicin to kill extra-cellular bacteria. Cells were then
washed and lysed in 1% Triton X-100 in sterile H2O, and
then plated on CLED agar plates (Oxoid, Basingstoke,
Table 3: Phenotyping of E. coli blood isolates.
Strains Internalisation rate (NHS/HIS) Type 1- fimbriae P- fimbriae CNF1 Serum resistance α-Haemolysin
J96 25 P P P P P
Internalised
B1 6.3 P P P P P
B2 33 P P P P P
B3 19 P N N P N
Non-internalised
B4 3.5 P P P P P
B5 3.3 P P N P P
B6 3.0 N P N P P
B7 1.2 N P N P P
B8 1.5 N P N P N
B9 2 N P N P N
B10 1.2 N P N P N
B11 0.7 N N P P P
B12 1.3 N N N P P
B13 1 N N N P N
B14 0.5 N N N P N
B15 2.2 N N N P N
In 15 blood isolates, bacterial virulence factors (including type-1, P fimbriae, CNF1, serum resistance, and α-Haemolysin) were examined to 
determine their correlation to C3-dependent internalisation (P positive, N negative). All experiments were repeated at least three times.
Table 2: The association between virulence factors and C3-dependent internalisation in urine isolates.
Bacterial virulence factors Strains demonstrating C3-dependent 
internalisation
Strains not demonstrating C3-dependent 
internalisation
Fischer's exact test
Type 1 fimbriae 7/7 (100%) 2/9 (22.2%) P = 0.0032*
P fimbriae 1/7 (14.3%) 1/9 (11.1%) nsd
CNF1 3/7 (42.9%) 3/9 (33.3%) nsd
Serum resistance 7/7 (100%) 7/9 (77.8%) nsd
Haemolysin 2/7 (28.6%) 3/9 (33.3%) nsd
The strength of association between virulence factors and C3-dependent internalisation was determined using Fischer's exact test.Page 4 of 9
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and the c.f.u counted. To investigate the involvement of
type 1 fimbriae in the complement -dependent internali-
sation process, D-mannose or glucose was added to PTEC
monolayers 20 minutes before bacteria were added and
the internalisation assay carried out as above. In each
experiment assays were performed in quadruplicate.
Assessment of bacterial fimbrial adhesin expression
Expression of fimbriae was determined by haemaggluti-
nation of guinea pig (Harlan SeraLab, Loughborough,
UK) or human erythrocytes in the presence and absence of
mannose. Erythrocytes were prepared in 0.85% sodium
chloride or 50 mM D-mannose in 0.85% sodium chloride
(3% v/v). Bacterial cultures were centrifuged at 6,000 g for
6 minutes and resuspended to 1 × 1010 cfu/ml in 0.85%
sodium chloride. One hundred μl of E. coli suspension
was added to an equal volume of erythrocyte solution on
white tiles and gently rocked at room temperature for two
minutes. Agglutination of guinea pig erythrocytes and the
inhibition of agglutination in the presence of D-mannose
confirmed the presence of type 1 fimbriae. P fimbriae
were identified by agglutination of human erythrocytes
that was not inhibited by addition of mannose.
Detection of haemolysin production
To demonstration of haemolysin production bacteria were
serially diluted 1 in 10 in PBS and 20 μl (about 2 × 106 bac-
teria) plated onto sheep blood agar (Oxoid). Plates were
incubated for 16 hours at 37°C. Production of haemolysin
was determined by haemolysis of the sheep erythrocytes
producing a clear ring of agar around individual colonies.
Presence of the CNF1 gene
CNF1 gene expression was determined by RT-PCR. The
genomic DNA from E. coli strains was extracted using a
quick alkaline lysis method [17]. A single colony was sus-
pended in 25 μl of 0.5 N NaOH and incubated at room
temperature for 30 minutes. 25 μl of 1 M HCl was added
and the lysate diluted in 450 μl of sterile water, spun at
6,000 g for 6 minutes and the supernatant collected. PCR
was carried out with 5 μl of lysate, 12.5 pmol each of
primers (5'-CGCTTGGACTGGGGATAATT-3' and 5'-
CTTCATAGTAGATGCCGCTC-3'), 200 μM of dNTPs, 3 U
of GoTaq® DNA Polymerase in a 25 μl of reaction buffer
(Promega, Southampton, UK). The PCR cycle consisted of
40 seconds of denaturation at 94°C, 1 minute of primer
annealing at 35°C, and 1 minute of extension/synthesis at
72°C. After 30 cycles of amplification, samples were incu-
bated for another 10 minutes at 72°C. A 401 bp PCR
products were visualised after electrophoresis on 1.2%
agarose gel containing ethidium bromide.
Serum sensitivity assay
Serum sensitivity was assessed according to the method of
Miller and Robinson [18]. 108 cfu/ml of bacteria were
washed and incubated in serially diluted NHS or HIS (in
PBS) for 1 hour at 37°C. Samples of the bacterial suspen-
sion (50 μl of 1 in 105 dilutions) were plated onto agar
plates. Serum resistance was determined by comparing
the number of colonies from cultures incubated in NHS
with those incubated in HIS. Serum resistance was defined
as killing of less than 50% of organisms, intermediate
resistance as killing of 50–99%, and serum sensitivity as >
99% of bacteria killed following incubation in up to 50%
normal human serum.
Statistical analysis
Bacteria binding and internalisation assays were performed
in 4 replicate wells. Data from two separate experiments
(total 8 wells) was pooled and analysed by students t-test
for comparison of two variables, ANOVA with Bonferroni
post test for multiple comparisons, Mann Whitney test or
Fischer's exact test. P < 0.05 was regarded as significant.
Results
C3-dependent internalisation of E. coli isolates by PTECs
The ability of uro-epithelial cells to internalise bacteria
has been recognised for some time. Our previous study
suggested that the E. coli strain J96 can utilise C3 to
increase internalisation into human PTECs. However it is
still unknown whether this is a general feature of E. coli.
Therefore, we determined whether C3-dependent inter-
nalisation by PTECs is seen with E. coli isolates from
patients with acute UTI.
16 E. coli isolates from the urine of patients with symp-
toms of acute lower UTI (Figure 1A) and 15 isolated from
Table 4: The association between virulence factors and C3-dependent internalisation in blood isolates.
Bacterial virulence factors Strains demonstrating C3 -dependent 
internalisation
Strains not demonstrating C3-dependent 
internalisation
Fischer's exact test
Type 1 fimbriae 3/3 (100%) 2/12 (16.7%) P = 0.0338
P fimbriae 2/3 (66.7%) 7/12 (58.3%) nsd
CNF1 2/3 (66.7%) 2/12 (16.7%) nsd
Serum resistance 3/3 (100%) 12/12 (100%) nsd
Haemolysin 2/3 (66.7%) 6/12 (50.0%) nsd
The strength of association between virulence factors and C3-dependent internalisation in blood isolates was determined using Fischer's exact test.Page 5 of 9
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Mannose prevents type 1 fimbriated E. coli binding to and invasion of PTECsFigure 3
Mannose prevents type 1 fimbriated E. coli binding to and invasion of PTECs. (A) Binding of type 1 fimbriated E. coli 
(J96) to PTECs was assessed in the presence or absence of mannose. Mannose was added to the cells 30 minutes before the 
addition of bacteria and serum. Mannose prevents type 1 fimbriae-mediated binding in a concentration-dependent manner (> 
80% inhibition in the presence of 3% mannose). P values are for comparisons between the absence and presence of mannose. * 
P < 0.005, **, P < 0.001. (B) Internalisation of type 1 fimbriated E. coli (J96) by PTEC was assessed in the presence of either 
mannose or glucose. 3% mannose or glucose was added to the cells 30 minutes before the addition of bacteria and serum. The 
presence of mannose significantly reduced the rate of bacterial internalisation (***, P < 0.0001 compared with Glucose). The 
results are representative of 3 separate experiments. Mean+/- SEM, n = 3 per experiment.
5% NHS + + + + 
Mannose W/O 1% 3% 5% 
0.0
2.5
5.0
7.5
10.0
12.5
Co
lo
ny
 fo
rm
in
g 
un
its
(?
10
4
)
0
500
1000
1500
2000
2500
Co
lo
ny
 fo
rm
in
g 
un
its
5% Serum NHS HIS NHS NHS
W/O Glucose MannoseW/O
A
B
*
** **
***
*
BMC Microbiology 2009, 9:64 http://www.biomedcentral.com/1471-2180/9/64blood cultures (patients with simultaneous UTI) (Figure
1B) were assessed to determine whether they demon-
strated C3-dependent internalisation. The number of
intracellular bacteria was quantified after co-incubation of
PTECs and E. coli isolates in the presence of 5% NHS or
HIS. Only some E. coli isolates showed an increase in the
number of intracellular bacteria after incubation with
NHS (as a source of C3). The ratio of intracellular bacteria
in the presence of NHS and HIS was used to assess the
effect of complement on internalisation (8 replicate wells
were used for each strain). C3-dependent internalisation
was arbitrarily defined as a five-fold increase in the
number of bacteria internalised in the presence of NHS
compared with HIS. Using this criterion, 7 isolates from
urine culture (44%, Figure 1C) and 3 isolates from blood
(20%, Figure 1D) demonstrated C3-dependent internali-
sation. Therefore, by this criterion, C3-dependent inter-
nalisation is not a feature of all strains of E. coli, suggesting
the requirement for a strain-dependent bacterial factor to
act synergistically with complement opsonisation.
The level of C3 opsonisation of E. coli isolates
Opsonisation of the bacteria by C3 is critical for C3-
dependent internalisation. Following activation, C3 is
cleaved into C3a and C3b, exposing an internal thiolester
bond allowing the C3b to bind covalently to hydroxyl
groups (carbohydrates) or amine groups (proteins) on the
pathogen surface. To determine the level of C3b deposi-
tion on the surface of the E. coli isolates, we performed C3
Western blotting using elute from isolates incubated with
5% NHS. The intensity of C3b was comparable in isolates
irrespective of whether or not they demonstrated C3-
dependent internalisation (Figure 2). Therefore, the
differences in internalisation could not be explained by
differences in the level of complement opsonisation.
Virulence factors that lead to heterogeneity between E. 
coli isolates
Three broad classes of virulence factors have been identi-
fied in E. coli associated with UTI: adhesins,
siderophores(aerobactin), and toxins. Other factors, such
as capsules, lipopolysaccharide and serum sensitivity may
also be important. Therefore, we examined the expression
of these factors in the 31 E. coli isolates.
Table 1 shows the prevalence of virulence factors among
the 16 urine E. coli isolates. Type 1 fimbriae were found in
all (7/7) of the isolates demonstrating C3-dependent
internalisation, whereas only two out of 9 strains that did
not show C3-dependent internalisation had type 1
fimbriae (Table 2, P = 0.0032, Fischer's exact test). The
presence of P fimbriae, expression of CNF1 or α-haemo-
lysin were not associated with C3 dependent internalisa-
tion. As would be predicted from previous reports, there
was a genetic linkage between the presence of cnf1+ and
the gene for α-haemolysin, hly+, in these isolates. But this
did not associate with C3-dependent internalisation.
Most strains studied were resistant to the lytic effects of
complement (Table 1).
In fifteen blood isolates, type 1 fimbriae were also
expressed by all of the isolates demonstrating C3-depend-
ent internalisation (P = 0.0338, Fischer's exact test) (table
3 and 4). A greater proportion of blood isolates expressed
invasion factors such as P fimbriae and α-haemolysin
than urine isolates, as would be predicted from previous
reports [19,20], however their presence did not correlate
with C3-dependent internalisation.
Effects of mannose on bacterial binding and C3-dependent 
internalisation
Previous studies have shown that type 1 fimbriae alone can
mediate pathogen adherence to host epithelium and induce
pathogen internalisation [9]. Mannose can prevent type 1
fimbriae-mediated bacterial adherence to uroepithelial cells.
Therefore, we used mannose blockade to study the interac-
tion between type 1 fimbriae-mediated bacterial adherence/
internalisation and C3 opsonisation. Assessment of bacterial
binding showed that the presence of mannose in culture
medium inhibited type 1 fimbriae-mediated J96 binding to
PTECs in a dose dependent manner (Figure 3A). 3% man-
nose also reduced C3-dependent internalisation by PTECs.
In contrast the same concentration of glucose had no effect
on bacterial internalisation (Figure 3B). Therefore, blocking
type 1 fimbriae-mediated binding can efficiently inhibit C3-
dependent internalisation.
FimH mediates opsonised E. coli adherence and invasion of 
PTECs
FimH mutation provided another means of blocking type 1
fimbriae-mediated bacterial adherence and internalisation
of human PTECs. Type 1-fimbriated cystitis isolate, NU14 or
the isogenic Fim H- mutant NU14-1 were co-cultured with
PTECs in the presence of 5% NHS. As shown in Figure 4, a
significant reduction in the number of bacteria bound to and
internalised by PTECs were seen in FimH- mutant strain
compared to the type 1 fimbriated wild type strain (Figure
4). This result further confirmed that type 1 fimbriae-medi-
ated binding is required for C3-dependent internalisation.
Discussion
Whether or not complement opsonisation increased
internalisation into renal epithelial cells was assessed for
16 E. coli isolates from the urine of patients with cystitis
and 15 isolated from blood cultures taken from patients
with simultaneous UTI. Not all E. coli isolates demon-
strated C3-dependent internalisation (taken arbitrarily as
a five-fold increase in bacterial internalisation in the pres-
ence of a source of complement). This was only evident in
44% of urinary and 20% of blood isolates. Complement
proteins are present in the urine and their concentration
increases significantly in the presence of urinary tractPage 7 of 9
(page number not for citation purposes)
BMC Microbiology 2009, 9:64 http://www.biomedcentral.com/1471-2180/9/64infection, sufficient to opsonise bacteria [13,14]. There-
fore isolates of E. coli which were internalised more effi-
ciently when opsonised may be able to gain access to a
favourable intracellular niche, protected from immune
attack and antibiotic treatment. Whether these isolates are
more likely to cause persistent or recurrent infection has
not been addressed in this current study.
We next investigated whether there was an association
between a specific bacterial phenotype and increased
internalisation when opsonised with complement. All
strains that demonstrated C3-dependent internalisation
also expressed type 1 fimbriae, suggesting that there is co-
operation between C3 and type 1 fimbriae to achieve
maximal bacterial internalisation. To confirm the impor-
tance of type 1 fimbriae, internalisation was assessed in
the presence of excess mannose to prevent type 1 fim-
briae-mediated binding to epithelial cells. Only very low
levels of internalisation were seen under these conditions,
even in the presence of complement opsonisation. There-
fore, type 1 fimbriae-mediated binding is an absolute
requirement for internalisation irrespective of C3 opsoni-
sation. In addition, a deletion of the FimH adhesin signif-
icantly abrogated binding and intracellular invasion of
opsonised E. coli, further confirming that type 1 fimbria-
tion is required for C3-dependent internalisation.
We could not demonstrate a role for P fimbriae in intra-
cellular invasion by E. coli. P fimbriae, and specifically the
class II PapG adhesin, are clinically associated with acute
pyelonephritis in humans. They bind to Gal(α1-4)Galβ
moieties present in membrane glycolipids of the human
kidney [21]. Fimbrial transformation and mutant studies
have suggested P fimbriae can enhance bacterial binding
and induce a robust inflammatory response during the
early kidney colonisation [22]. However, consistent with
our present data, a previous study on bladder cells sug-
gested that adherence mediated by the PapG did not result
bacteria internalisation [9].
Notably, the percentage of isolates expressing type 1 fim-
briae is much lower in bacteraemia isolates than in uri-
nary isolates (33% versus 56%). In contrast a higher
percentage expressing P fimbriae was seen (60% versus
12.5%) in bacteraemia isolates. It is likely that 'crosstalk'
occurs between the regulators of the different fimbrial sys-
tems in pathogenic E. coli. Classically pyelonephritis
Diagram showing possible involvement of both CD46 and type 1 fimbrial receptor sig alling in the internalisation of E. coli by PTECsFigure 5
Diagram showing possible involvement of both CD46 
and type 1 fimbrial receptor signalling in the internal-
isation of E. coli by PTECs. Internalisation of E. coli is initi-
ated by type 1 fimberiae mediated adhesion to epithelium 
mannosylated glycoproteins receptor. This may be sufficient 
to induce internalisation alone. However, during UTI, E. coli 
can be opsonised by urine C3 in urinary tract space. C3b 
bound on bacteria surface interact with cell surface 
expressed CD46. This C3b-CD46 interaction could activate 
host cells and augments the direct interaction of fimH with 
manosylated receptor resulting in a high internalisation. Inhi-
bition and FimH mutant experiments indicate that non-
opsonic interactions are necessary for E. coli adherence to 
and invasion of PTECs.
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FimH mediates opsonised E. coli adherence and invasion of PTECsigure 4
FimH mediates opsonised E. coli adherence and inva-
sion of PTECs. Adherence assays (A) and internalisation 
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strains are more likely to contain and express P fimbrial
gene clusters and therefore down-regulate type 1 fimbriae
expression [23]. This may explain the different patterns of
clinical infection caused by different strains of E. coli.
Conclusion
Type 1 fimbriae mediated-binding is essential for C3-
dependent internalisation. We do not know whether this
is a co-operative, synergistic action or the additive activi-
ties of two factors. Since, FimH alone can mediate intra-
cellular invasion, we suggest that the C3 opsonisation
augments the signalling initiated by FimH-mediated
binding (Figure 5). Studies to analyse the mechanism by
which C3 receptor(s) (CD46) and the receptors for FimH
interact are important to fully understand invasion of
human urinary tract by pathogenic E. coli.
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